NCT04030455 2026-03-09Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal CancerM.D. Anderson Cancer CenterPhase 2 Active not recruiting28 enrolled 13 charts
NCT03174275 2026-02-23Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell CarcinomaUNC Lineberger Comprehensive Cancer CenterPhase 2 Active not recruiting39 enrolled 8 charts